Wataru Ogura - Search Results

Year	Number of Results
2010	1
2019	1
2020	2
2021	1
2022	1
2023	0

1

Can Individuals with Suboptimal Antibody Responses to Conventional Antiviral Vaccines Acquire Adequate Antibodies from SARS-CoV-2 mRNA Vaccination?

Ogura W, Ohtsuka K, Matsuura S, Okuyama T, Matsushima S, Yamasaki S, Miyagi H, Sekiguchi K, Ohnishi H, Watanabe T. Ogura W, et al. Viruses. 2022 May 3;14(5):956. doi: 10.3390/v14050956. Viruses. 2022. PMID: 35632698 Free PMC article.

2

Predisposition to Lung Adenocarcinoma in a Family Harboring the Germline EGFR V843I Mutation.

Ohtsuka K, Ohnishi H, Fujiwara M, Morii T, Matsushima S, Ogura W, Yamasaki S, Kishino T, Tanaka R, Watanabe T. Ohtsuka K, et al. Among authors: ogura w. JCO Precis Oncol. 2019 Jul 26;3:PO.19.00104. doi: 10.1200/PO.19.00104. eCollection 2019. JCO Precis Oncol. 2019. PMID: 32914005 Free PMC article. No abstract available.

3

Establishing an internal quality control method for the stable extraction of nucleic acids of severe acute respiratory syndrome coronavirus 2 and RT-PCR-based detection.

Okuyama T, Ohtsuka K, Ogura W, Yonetani S, Yamasaki S, Miyagi H, Sekiguchi K, Ohnishi H, Watanabe T. Okuyama T, et al. Among authors: ogura w. J Clin Lab Anal. 2021 Nov;35(11):e23998. doi: 10.1002/jcla.23998. Epub 2021 Oct 2. J Clin Lab Anal. 2021. PMID: 34599840 Free PMC article.

4

Subtyping and EGFR mutation testing from blocks of cytological materials, based on liquid-based cytology for lung cancer at bronchoscopic examinations.

Tanaka R, Ohtsuka K, Ogura W, Arai N, Yoshida T, Nakazato Y, Tachibana K, Takata S, Fujiwara M, Kamma H, Shibahara J, Kondo H. Tanaka R, et al. Among authors: ogura w. Diagn Cytopathol. 2020 Jun;48(6):516-523. doi: 10.1002/dc.24397. Epub 2020 Mar 3. Diagn Cytopathol. 2020. PMID: 32125777

5

Use of a plasma test for verifying epidermal growth factor receptor gene (EGFR) mutations in fluid samples from non-small cell lung cancer patients.

Ogura W, Ohtsuka K, Fujiwara M, Tanaka R, Sekiguchi K, Ohnishi H, Watanabe T. Ogura W, et al. Respir Med Case Rep. 2020 Jan 27;29:101007. doi: 10.1016/j.rmcr.2020.101007. eCollection 2020. Respir Med Case Rep. 2020. PMID: 32025485 Free PMC article.

6

Downregulated ABCG2 enhances sensitivity to topoisomerase I inhibitor in epidermal growth factor receptor tyrosine kinase inhibitor-resistant non-small cell lung cancer.

Ohtsuka K, Ohnishi H, Morii T, Fujiwara M, Kishino T, Ogura W, Chiba M, Matsushima S, Goya T, Watanabe T. Ohtsuka K, et al. Among authors: ogura w. J Thorac Oncol. 2010 Nov;5(11):1726-33. doi: 10.1097/JTO.0b013e3181f0b6af. J Thorac Oncol. 2010. PMID: 20975373 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

6 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year